Jeffrey Allen Bailey's Net Worth

$13.5 Million

Estimate Recalculated Jul 18, 2024 02:00PM EST

Who is Jeffrey Allen Bailey?

Jeffrey Allen Bailey has an estimated net worth of $13.5 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Lantheus Holdings, Inc., TEKLA HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, TEKLA LIFE SCIENCES INVESTORS, LANDAUER INC, AILERON THERAPEUTICS INC, KING PHARMACEUTICALS INC, and Aurinia Pharmaceuticals Inc..

SEC CIK

Jeffrey Allen Bailey's CIK is 0001500210

Past Insider Trading and Trends

2020 was Jeffrey Allen Bailey's most active year for acquiring shares with 15 total transactions. Jeffrey Allen Bailey's most active month to acquire stocks was the month of October. 2022 was Jeffrey Allen Bailey's most active year for disposing of shares, totalling 8 transactions. Jeffrey Allen Bailey's most active month to dispose stocks was the month of February. 2022 saw Jeffrey Allen Bailey paying a total of $4,185,089.22 for 1,408,218 shares, this is the most they've acquired in one year. In 2017 Jeffrey Allen Bailey cashed out on 8,943 shares for a total of $601,416.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIODELIVERY SCIENCES INTERNATIONAL INC No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-105.13K
—
—
0
Mar 22
Form 4
+5.34%
5.33K
—
—
105.13K
Mar 9
Form 4
—
0
—
—
0
Jan 27
Form 4
+114.78%
53.33K
—
—
99.8K
Nov 4
Form 4
+13.61%
5.57K
—
—
46.47K
Aug 6
Form 4
+14.99%
5.33K
—
—
40.9K
Mar 9
Form 4
-21.95%
-10.00K
$4.35
-$43,500.00
35.57K
Dec 15
Form 4
+718.52%
40K
—
—
45.57K
Nov 4
Form 4
∞
5.57K
—
—
5.57K
Aug 7
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Mar 9
Form 3
—
0
—
—
0
No matching records found

Lantheus Holdings, Inc. (LNTH) Snapshot price: $54.855

CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-5.37%
-13.02K
$7.13
-$92,832.60
229.41K
Jul 17
Form 4
-74.87%
-181.49K
—
—
60.93K
Aug 31
Form 4
+19.76%
40K
—
—
242.43K
Jul 17
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

TEKLA HEALTHCARE INVESTORS (HQH) Snapshot price: $17.185

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
490
$20.39
$9,991.10
490
Sep 23
Form 3
—
0
—
—
0
No matching records found

Tekla Healthcare Opportunities Fund (THQ) Snapshot price: $18.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
570
$17.68
$10,077.60
570
Sep 23
Form 3
—
0
—
—
0
No matching records found

Tekla World Healthcare Fund (THW) Snapshot price: $12.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+33.33%
245
$14.26
$3,494.19
980
Apr 6
Form 4
∞
710
$14.18
$10,067.80
710
Sep 23
Form 3
—
0
—
—
0
No matching records found